Martin Shkreli's one-time turnaround project, KaloBios, files for bankruptcy reorganization

KaloBios Pharmaceuticals Inc. — the pet project of indicted former hedge fund manager and drug industry executive Martin Shkreli — filed late Tuesday for Chapter 11 bankruptcy reorganization...